C07D501/16

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER

Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express a tumor antigen-targeted chimeric antigen receptor and a prodrug converting enzyme.